Company CVAbout Divis Laboratories Ltd 
Divis Laboratories Ltd
Large Cap
Pharmaceuticals & Biotechnology
Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals. The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries. It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports.
Company Coordinates
Company Details
1-72-23(P)/DIVIS/303 Divi Towe, Cyber Hills Gachibowli Hyderabad Telangana : 500032
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 53.09 Cr
Number of Shares
26.55 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
23-Sep-2015
26.55
53.09
132734290
2
Bonus
23-Sep-2015
26.55
53.09
132734290
2
Bonus
05-Mar-2012
13.27
26.55
31180
2
ESOP
05-Mar-2012
13.27
26.55
31180
2
ESOP
01-Nov-2011
13.27
26.54
26560
2
ESOP
01-Nov-2011
13.27
26.54
26560
2
ESOP
06-Aug-2011
13.27
26.54
26520
2
ESOP
06-Aug-2011
13.27
26.54
26520
2
ESOP
20-May-2011
13.27
26.53
54920
2
ESOP
20-May-2011
13.27
26.53
54920
2
ESOP
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 43 Schemes (13.99%)
FIIs
Held by 786 FIIs (19.39%)
Promoter with highest holding
Nilima Prasad Divi (20.34%)
Highest Public shareholder
Sbi Mutual Fund (4.75%)
Individual Investors Holdings
6.78%
Board of Directors
Management
Designation
Remuneration
Murali K Divi
Chairman & Managing Director
70.49 cr
N V Ramana
Executive Director
36.31 cr
Madhusudana Rao Divi
Whole Time Director (Projects)
1.15 cr
Kiran S Divi
Whole Time Director & CEO
24.79 cr
G Suresh Kumar
Independent Director
32.0 lacs
Ranga Rao Ravipati
Independent Director
34.0 lacs
K V K Seshavataram
Independent Director
30.0 lacs
Ramesh B V Nimmagadda
Chairman(Non Exe)&Director(Ind
32.0 lacs
Nilima Motaparti
Whole Time Director -Commercia
24.63 cr
S Ganapaty
Independent Director
28.0 lacs
Sunaina Singh
Independent Director
25.0 lacs
Kosaraju Veerayya Chowdary
Independent Director
30.0 lacs
Satish Choudhury
Company Sec. & Compli. Officer
38.0 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Active Pharma Ingredients and Intermediates
4,727.84
96.89%
Other Operating Revenue - Export Incentives
116.91
2.40%
Other Operating Revenue - Scrap
25.53
0.52%
Active Pharma Ingredients and Intermediates
Active Pharma Ingredients and Intermediates
Other Operating Revenue - Export Incentives
Other Operating Revenue - Export Incentives
Other Operating Revenue - Scrap
Other Operating Revenue - Scrap
Stock DNARevenue and Profits:
Net Sales:
2,715 Cr
(Quarterly Results - Sep 2025)
Net Profit:
689 Cr
Pharmaceuticals & Biotechnology
INR 171,227 Cr (Large Cap)
69.00
27
0.47%
-0.21
16.12%
11.05
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
